BB Biotech AG Cash Flow-to-Debt Ratio
BB Biotech AG cash flow-to-debt ratio. BB Biotech AG (BION) has a Cash Flow-to-Debt Ratio of -28.52x as of June 2026, meaning its operating cash flow of CHF-150.88 Million could theoretically repay -29% of its total liabilities (CHF5.29 Million) in one year. Check BB Biotech AG cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of BB Biotech AG (2003–2025)
Cash flow-to-debt ratio of BB Biotech AG from 2003 to 2025. Historical debt coverage capacity for BB Biotech AG across 23 annual periods. Check cash flow reinvestment rate of BB Biotech AG to assess the company's total reinvestment commitment from operating cash flow.
BB Biotech AG Cash Flow-to-Debt Ratio by Year (2003–2025)
BB Biotech AG cash flow-to-debt ratio by year from 2003 to 2025. Year-by-year debt coverage analysis for BB Biotech AG. For the full cash flow conversion analysis, see cash flow conversion of BB Biotech AG.
| Year | CF-to-Debt Ratio | Operating CF (CHF) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 44.33x | CHF309.14 Million | CHF6.97 Million | ▲ +1662.7% |
| 2024 | 2.51x | CHF304.56 Million | CHF121.11 Million | ▲ +261.7% |
| 2023 | 0.70x | CHF218.28 Million | CHF313.94 Million | ▲ +171.4% |
| 2022 | -0.97x | CHF-357.81 Million | CHF367.25 Million | ▲ +14.6% |
| 2021 | -1.14x | CHF-404.81 Million | CHF355.00 Million | ▼ -127.4% |
| 2020 | 4.17x | CHF262.45 Million | CHF63.00 Million | ▲ +213.1% |
| 2019 | 1.33x | CHF215.02 Million | CHF161.59 Million | ▲ +157.1% |
| 2018 | -2.33x | CHF-471.34 Million | CHF202.33 Million | ▼ -133.6% |
| 2017 | 6.94x | CHF687.50 Million | CHF99.12 Million | ▲ +293.0% |
| 2016 | -3.59x | CHF-802.07 Million | CHF223.22 Million | ▼ -191.1% |
| 2015 | 3.94x | CHF652.82 Million | CHF165.51 Million | ▼ -89.2% |
| 2014 | 36.51x | CHF1.47 Billion | CHF40.27 Million | ▲ +260.5% |
| 2013 | 10.13x | CHF931.83 Million | CHF92.00 Million | ▲ +285.3% |
| 2012 | 2.63x | CHF367.83 Million | CHF139.94 Million | ▲ +132.4% |
| 2011 | 1.13x | CHF169.52 Million | CHF149.89 Million | ▲ +786.7% |
| 2010 | -0.16x | CHF-23.41 Million | CHF142.15 Million | ▼ -100.5% |
| 2009 | 36.28x | CHF167.84 Million | CHF4.63 Million | ▲ +714.6% |
| 2008 | 4.45x | CHF509.39 Million | CHF114.37 Million | ▲ +586.5% |
| 2007 | 0.65x | CHF201.02 Million | CHF309.83 Million | ▲ +1085.6% |
| 2006 | -0.07x | CHF-19.80 Million | CHF300.86 Million | ▼ -134.0% |
| 2005 | -0.03x | CHF-6.14 Million | CHF218.35 Million | ▼ -100.1% |
| 2004 | 29.92x | CHF107.32 Million | CHF3.59 Million | ▲ +855.9% |
| 2003 | -3.96x | CHF-172.22 Million | CHF43.51 Million | — |